跳至主要内容
临床试验/ISRCTN46679573
ISRCTN46679573已完成1 期

A double-blind, placebo-controlled pilot study to evaluate FruitexB® (calcium fructoborate) effect on systemic inflammation and dyslipidaemia markers in middle-aged people with primary osteoarthritis

atural Research, Ltd (Romania)0 个研究点目标入组 72 人开始时间: 2010年3月17日最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
发起方
入组人数
72

研究概览

简要总结

2011 results in https://pubmed.ncbi.nlm.nih.gov/21607703/ (added 29/12/2020)

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Men and non-pregnant women
  • 2. Aged 40 - 85 years
  • 3. Primary OA of at least one knee as demonstrated by a radiological examination carried out within the previous 3 months
  • 4. Body mass index (BMI) less than 28 and greater than 24.4 kg/m^2
  • 5. Elevated blood levels of at least one inflammatory marker

排除标准

  • 1. Individuals with digestion problems
  • 2. Subjects with a fever and/or under treatment with antibiotics
  • 3. Subjects with fructose intolerance
  • 4. Subjects taking any painkillers and/or vitamin B6
  • 5. Subjects taking aspirin
  • 6. Current use of non-steroidal anti-inflammatory drugs (NSAIDS) and acetominophen

研究者

发起方
atural Research, Ltd (Romania)

相似试验